Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells

被引:34
作者
Kim, YJ
Brutkiewicz, RR
Broxmeyer, HE
机构
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[2] Walther Canc Inst, Indianapolis, IN USA
关键词
D O I
10.1182/blood-2001-11-0136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The CD28(-) subset of CD8(+) T cells is associated with cytotoxic T lymphocyte (CTL) effector function. We investigated a potential role for 4-1BB, a costimulatory molecule structurally related to members of the tumor necrosis factor (TNF) receptor family, in the generation and functional activation of CD28(-) CTLs by using human cord blood (CB) cells composed exclusively of naive CD8+ T cells with few or no CD28(-) CTLs. The 4-1BB was induced preferentially on the CB CD28(-)CD8(+) T cells when CD28 down-regulation was induced by interleukin 15 (IL-15) and IL-12 stimulation. Anti-4-1BB costimulation induced dramatic phenotypic changes in the CD28- CTLs, including restoration of CD28 expression as well as that of memory markers such as CD45RO and CC chemokine receptor 6 (CCR6). Anti-4-1BB costimulation also promoted long-term survival of CD28(-) CTLs, which were sensitive to activation-induced cell death upon anti-CD3 stimulation. The memory-type CD28(+) CTLs induced by anti-4-1BB costimulation acquired a greatly enhanced content of granzyme B, a cytolytic mediator, and enhanced cytotoxic activity as compared with CD28(-) CTLs. Strong cytotoxicity of memory-type CTLs to a 4-1BB ligand-expressing Epstein-Barr virus (EBV)-transformed B-cell line was almost completely abrogated by 4-1BB-Fc, a soluble form of 4-1BB, suggesting involvement of 4-1BB in cytolytic processes. Taken all together, our results suggest that 4-1BB plays a role in the differentiation of effector memory CTLs. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3253 / 3260
页数:8
相关论文
共 65 条
[21]   Phenotypic and functional separation of memory and effector human CD8(+) T cells [J].
Hamann, D ;
Baars, P ;
Rep, MHG ;
Hooibrink, B ;
KerkhofGarde, SR ;
Klein, MR ;
vanLier, RAW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1407-1418
[22]   Faces and phases of human CD8+ T-cell development [J].
Hamann, D ;
Roos, MTL ;
van Lier, RAW .
IMMUNOLOGY TODAY, 1999, 20 (04) :177-180
[23]  
Hurtado JC, 1997, J IMMUNOL, V158, P2600
[24]   Memory CD8+ T cell differentiation:: initial antigen encounter triggers a developmental program in naive cells [J].
Kaech, SM ;
Ahmed, R .
NATURE IMMUNOLOGY, 2001, 2 (05) :415-422
[25]  
Kim YJ, 1998, EUR J IMMUNOL, V28, P881, DOI 10.1002/(SICI)1521-4141(199803)28:03<881::AID-IMMU881>3.0.CO
[26]  
2-0
[27]   Therapeutic potential of 4-1BB (CD137) as a regulator for effector CD8+ T cells [J].
Kim, YJ ;
Broxmeyer, HE .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (04) :441-449
[28]  
Kostense S, 2001, EUR J IMMUNOL, V31, P677, DOI 10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO
[29]  
2-M
[30]  
Lee SM, 1996, BLOOD, V88, P945